AI assistant
Sending…
BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012
Mar 19, 2012
31868_dirs_2012-03-19_a3784ca0-26d3-43ba-89a1-fb79864f6dc7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-03-15
Reporting Person: Babu Yarlagadda S (VP Drug Discovery)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-15 | Common Stock | A | 21038 | — | Acquired | 146807 | Direct |
| 2012-03-15 | Common Stock | F | 6872 | $5.23 | Disposed | 139935 | Direct |
Footnotes
F1: Restricted Stock Award-100% vested upon issue with a six month lock up for sale
F2: Shares withheld by BioCryst Pharmaceuticals, Inc. upon the vesting of restricted stock to satisfy the reporting person's tax withholding obligation.
More from BIOCRYST PHARMACEUTICALS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20